Logo image of DHR

DANAHER CORP (DHR) Stock Overview

USA - NYSE:DHR - US2358511028 - Common Stock

209.06 USD
-1.86 (-0.88%)
Last: 10/17/2025, 8:06:46 PM
209.88 USD
+0.82 (+0.39%)
After Hours: 10/17/2025, 8:06:46 PM

DHR Key Statistics, Chart & Performance

Key Statistics
Market Cap149.70B
Revenue(TTM)24.01B
Net Income(TTM)3.41B
Shares716.05M
Float638.06M
52 Week High274.21
52 Week Low171
Yearly Dividend1.05
Dividend Yield0.61%
EPS(TTM)7.53
PE27.76
Fwd PE24.11
Earnings (Next)10-21 2025-10-21/bmo
IPO1969-12-10
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


DHR short term performance overview.The bars show the price performance of DHR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10

DHR long term performance overview.The bars show the price performance of DHR in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -10 -20

The current stock price of DHR is 209.06 USD. In the past month the price increased by 8.16%. In the past year, price decreased by -23.81%.

DANAHER CORP / DHR Daily stock chart

DHR Latest News, Press Relases and Analysis

DHR Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 24.62 203.50B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 139.64 45.55B
A AGILENT TECHNOLOGIES INC 26.04 40.23B
IQV IQVIA HOLDINGS INC 17.83 34.77B
MTD METTLER-TOLEDO INTERNATIONAL 32.99 27.80B
WAT WATERS CORP 27.36 19.91B
WST WEST PHARMACEUTICAL SERVICES 38.88 19.46B
TEM TEMPUS AI INC N/A 15.25B
MEDP MEDPACE HOLDINGS INC 39.26 14.83B
ILMN ILLUMINA INC 22.95 14.67B
ICLR ICON PLC 13.99 14.39B
RVTY REVVITY INC 19.1 10.84B

About DHR

Company Profile

DHR logo image Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.

Company Info

DANAHER CORP

2200 Pennsylvania Ave NW Ste 800W

WASHINGTON WASHINGTON DC 20037 US

CEO: Rainer M. Blair

Employees: 61000

DHR Company Website

DHR Investor Relations

Phone: 12028280850

DANAHER CORP / DHR FAQ

What is the stock price of DANAHER CORP today?

The current stock price of DHR is 209.06 USD. The price decreased by -0.88% in the last trading session.


What is the ticker symbol for DANAHER CORP stock?

The exchange symbol of DANAHER CORP is DHR and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is DHR stock listed?

DHR stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for DANAHER CORP stock?

29 analysts have analysed DHR and the average price target is 246.54 USD. This implies a price increase of 17.93% is expected in the next year compared to the current price of 209.06. Check the DANAHER CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is DANAHER CORP worth?

DANAHER CORP (DHR) has a market capitalization of 149.70B USD. This makes DHR a Large Cap stock.


How many employees does DANAHER CORP have?

DANAHER CORP (DHR) currently has 61000 employees.


What are the support and resistance levels for DANAHER CORP (DHR) stock?

DANAHER CORP (DHR) has a support level at 206.97 and a resistance level at 211.14. Check the full technical report for a detailed analysis of DHR support and resistance levels.


Is DANAHER CORP (DHR) expected to grow?

The Revenue of DANAHER CORP (DHR) is expected to grow by 3.84% in the next year. Check the estimates tab for more information on the DHR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy DANAHER CORP (DHR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does DANAHER CORP (DHR) stock pay dividends?

DANAHER CORP (DHR) has a dividend yield of 0.61%. The yearly dividend amount is currently 1.05. Check the full fundamental report for a detailed analysis of DHR dividend history, reliability and sustainability.


When does DANAHER CORP (DHR) report earnings?

DANAHER CORP (DHR) will report earnings on 2025-10-21, before the market open.


What is the Price/Earnings (PE) ratio of DANAHER CORP (DHR)?

The PE ratio for DANAHER CORP (DHR) is 27.76. This is based on the reported non-GAAP earnings per share of 7.53 and the current share price of 209.06 USD. Check the full fundamental report for a full analysis of the valuation metrics for DHR.


What is the Short Interest ratio of DANAHER CORP (DHR) stock?

The outstanding short interest for DANAHER CORP (DHR) is 1.49% of its float. Check the ownership tab for more information on the DHR short interest.


DHR Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to DHR. When comparing the yearly performance of all stocks, DHR is a bad performer in the overall market: 75.51% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

DHR Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to DHR. DHR has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DHR Financial Highlights

Over the last trailing twelve months DHR reported a non-GAAP Earnings per Share(EPS) of 7.53. The EPS decreased by -2.84% compared to the year before.


Industry RankSector Rank
PM (TTM) 14.21%
ROA 4.18%
ROE 6.52%
Debt/Equity 0.32
Chartmill High Growth Momentum
EPS Q2Q%4.65%
Sales Q2Q%3.36%
EPS 1Y (TTM)-2.84%
Revenue 1Y (TTM)1.89%

DHR Forecast & Estimates

29 analysts have analysed DHR and the average price target is 246.54 USD. This implies a price increase of 17.93% is expected in the next year compared to the current price of 209.06.

For the next year, analysts expect an EPS growth of 4.85% and a revenue growth 3.84% for DHR


Analysts
Analysts86.21
Price Target246.54 (17.93%)
EPS Next Y4.85%
Revenue Next Year3.84%

DHR Ownership

Ownership
Inst Owners82.47%
Ins Owners10.82%
Short Float %1.49%
Short Ratio2.33